Soluble P selectin in systemic sclerosis: relationship with von Willebrand factor, autoantibodies and diffuse or localised/limited disease.
Blann
A D
AD
Haemostasis, Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Dudley Road, Birmingham B18 7QH, UK. a.blann@bham.ac.uk
Constans
J
J
Carpentier
P
P
Renard
M
M
Satger
B
B
Guérin
V
V
Boisseau
M R
MR
Neau-Cransac
N
N
Conri
C
C
D000368:Aged; D000974:Antibodies, Antinuclear / Q000097:blood; D001323:Autoantibodies / Q000097:blood; D015415:Biomarkers / Q000097:blood; D016022:Case-Control Studies; D002503:Centromere / Q000276:immunology; D004264:DNA Topoisomerases, Type I / Q000276:immunology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D019007:P-Selectin / Q000097:blood*; D045743:Scleroderma, Diffuse / Q000097:blood; D045745:Scleroderma, Limited / Q000097:blood; D012595:Scleroderma, Systemic / Q000097:blood*; D012995:Solubility; D014841:von Willebrand Factor / Q000032:analysis
D000974:Antibodies, Antinuclear; D001323:Autoantibodies; D015415:Biomarkers; D019007:P-Selectin; D014841:von Willebrand Factor; D004264:DNA Topoisomerases, Type I